NCT02731521View on ClinicalTrials.gov

Clinical Development of MR Spectroscopy and Imaging in Brain Cancers

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Malignant GliomasAstrocytomasOligodendrogliomas
Interventions
DEVICE

3 Tesla Scanning

Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.

DEVICE

7 Tesla Scanning

Approximately 120 brain tumor patients 50 patients with non-glioma disease, and 5 healthy volunteers will be scanned at either 3 Tesla or 7 Tesla.

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT02731521 - Clinical Development of MR Spectroscopy and Imaging in Brain Cancers | Biotech Hunter | Biotech Hunter